becoming substantial shareholder

Calzada Limited, melbourne based biotech buys 102,352,939 shares for $2,983,104.27 =2.914c per share.

Looking at CZD's SP graph indicates that they have been as dismal as AVX at returning long term share holder value.

They reported a Half year loss to december 09 of 0.8 of a mil, so I can't see them getting any benefefit off a tax loss from AVX any time soon.

I suspect that there is information that has not been disclosed to the public that is driving this whole episode and that those in the know will benefit while the average share holder gets screwed yet again.